BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 116995
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116995
Table 1 Baseline demographic, clinical, laboratory features, fibrosis stage, and IFI16 (rs1057028) and AIM2 (rs2814770) genotypic and allelic frequency in the present study population
Characteristics
CHC patients (n = 378)
Age (years)40 (32-50)
BMI (kg/m2)26.8 (24-30)
HCV-RNA log10 (IU/mL)4.58 (3.75-5.41)
ALT (IU/L)59 (41-88)
AST (IU/L)55 (39.2-89.5)
Bilirubin (mg/dL)0.8 (0.7-0.9)
Metavir staging
    F0-F1223 (59.5)
    F217 (4.5)
    F359 (15.7)
    F476 (20.3)
IFI16 rs1057028 (n = 378)
    AA209 (55.3)
    AT100 (26.5)
    TT69 (18.3)
    A518 (69)
    T238 (31)
AIM2 rs2814770 (n = 140)
    CC41 (29.3)
    CT60 (42.9)
    TT39 (27.9)
    C142 (51)
    T138 (49)


Write to the Help Desk